Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Unemo

Showing results (321-330 of 438) with videos related to

Pageof 44
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 9, 2026
Sustained transmission advantage of ceftriaxone-resistant Neisseria gonorrhoeae in Tianjin, China: a retrospective genomic surveillance studyJingjin Zhu, Yanhong Zhao, Tielin Ning, et al.
Sexually Transmitted Diseases|January 13, 2015
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in EuropeMichelle J Cole, Gianfranco Spiteri, Katy Town, et al.
Mbio|April 5, 2018
<i>In Vivo</i>-Selected Compensatory Mutations Restore the Fitness Cost of Mosaic <i>penA</i> Alleles That Confer Ceftriaxone Resistance in <i>Neisseria gonorrhoeae</i>Leah R Vincent, Samuel R Kerr, Yang Tan, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in EuropeStephanie A Chisholm, Nerteley Quaye, Michelle J Cole, et al.
JCI Insight|October 30, 2019
C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infectionsSerena Bettoni, Jutamas Shaughnessy, Karolina Maziarz, et al.
Frontiers in Reproductive Health|May 6, 2024
Prevalence of sexually transmitted infections (STIs), associations with sociodemographic and behavioural factors, and assessment of the syndromic management of vaginal discharge in women with urogenital complaints in MozambiqueAlice Manjate, Gladys Sergon, Darlenne Kenga, et al.
Frontiers in Pharmacology|December 22, 2023
Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against <i>Neisseria gonorrhoeae</i> in a gonococcal hollow-fiber infection modelSusanne Jacobsson, Daniel Golparian, Joakim Oxelbark, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterizationMagnus Unemo, Daniel Golparian, Leonor Sánchez-Busó, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2024
The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterizationMagnus Unemo, Leonor Sánchez-Busó, Daniel Golparian, et al.
BMC Infectious Diseases|August 24, 2014
Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae - the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the originIbrahim Muhammad, Daniel Golparian, Jo-Anne R Dillon, et al.
Pageof 44

Showing results (321-330 of 438) with videos related to

Sort By:
Pageof 44
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 9, 2026
Sustained transmission advantage of ceftriaxone-resistant Neisseria gonorrhoeae in Tianjin, China: a retrospective genomic surveillance studyJingjin Zhu, Yanhong Zhao, Tielin Ning, et al.
Sexually Transmitted Diseases|January 13, 2015
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in EuropeMichelle J Cole, Gianfranco Spiteri, Katy Town, et al.
Mbio|April 5, 2018
<i>In Vivo</i>-Selected Compensatory Mutations Restore the Fitness Cost of Mosaic <i>penA</i> Alleles That Confer Ceftriaxone Resistance in <i>Neisseria gonorrhoeae</i>Leah R Vincent, Samuel R Kerr, Yang Tan, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in EuropeStephanie A Chisholm, Nerteley Quaye, Michelle J Cole, et al.
JCI Insight|October 30, 2019
C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infectionsSerena Bettoni, Jutamas Shaughnessy, Karolina Maziarz, et al.
Frontiers in Reproductive Health|May 6, 2024
Prevalence of sexually transmitted infections (STIs), associations with sociodemographic and behavioural factors, and assessment of the syndromic management of vaginal discharge in women with urogenital complaints in MozambiqueAlice Manjate, Gladys Sergon, Darlenne Kenga, et al.
Frontiers in Pharmacology|December 22, 2023
Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against <i>Neisseria gonorrhoeae</i> in a gonococcal hollow-fiber infection modelSusanne Jacobsson, Daniel Golparian, Joakim Oxelbark, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterizationMagnus Unemo, Daniel Golparian, Leonor Sánchez-Busó, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2024
The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterizationMagnus Unemo, Leonor Sánchez-Busó, Daniel Golparian, et al.
BMC Infectious Diseases|August 24, 2014
Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae - the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the originIbrahim Muhammad, Daniel Golparian, Jo-Anne R Dillon, et al.
Pageof 44